Entactbio

Watertown, US · 1 known investors

Entact Bio develops ENTAC small-molecule medicines that enhance the function of beneficial proteins by recruiting deubiquitylase (DUB) enzymes, using its Encompass drug-discovery platform to target a range of genetic and complex diseases. The company is a biotech firm developing targeted protein enhancement therapeutics.

BiotechDeep Tech